• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail

GRN No. 414

L-lysine monohydrochloride

Intended Use: To reduce the formation of acrylamide in fabricated snack products at use levels up to 1.5% (1.2% as lysine)
Basis: Scientific procedures
Notifier: The Procter & Gamble Company
Notifier Address: Winston Hill Business Center
6300 Center Hill Road
Cincinnati, OH 45224
Date of filing: Jan 12, 2012
GRAS Notice (releasable information): GRN 414 (in PDF)
Date of closure: Nov 20, 2012
FDA's Letter: FDA has no questions